BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Juday T, Tang H, Harris M, Powers AZ, Kim E, Hanna GJ. Adherence to chronic hepatitis B treatment guideline recommendations for laboratory monitoring of patients who are not receiving antiviral treatment. J Gen Intern Med 2011;26:239-44. [PMID: 20978862 DOI: 10.1007/s11606-010-1549-9] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.1] [Reference Citation Analysis]
Number Citing Articles
1 Scarponi CFO, Pedrosa MAF, Mol MPG, Greco DB. Noncompliance with Therapeutic Guidelines for Chronic Hepatitis B Patients in Minas Gerais, Brazil. Infectious Disease Reports 2022;14:955-966. [DOI: 10.3390/idr14060094] [Reference Citation Analysis]
2 Huang C, Yang H, Gao J, Yu Y, Lan C. Long-term monitoring, and hepatocellular carcinoma surveillance in patients with chronic hepatitis B infection.. [DOI: 10.21203/rs.3.rs-2257861/v1] [Reference Citation Analysis]
3 Katwaroe WK, Brakenhoff SM, van der Spek DPC, de Knegt RJ, van Kleef LA, de Man RA, van der Meer AJP, Sonneveld MJ; the ICARUS Study Group. Assessment of Adherence to Clinical Guidelines in Patients with Chronic Hepatitis B. Viruses 2022;14:2229. [DOI: 10.3390/v14102229] [Reference Citation Analysis]
4 Ma GX, Zhu L, Lu W, Handorf E, Tan Y, Yeh MC, Johnson C, Guerrier G, Nguyen MT. Improving Long-Term Adherence to Monitoring/Treatment in Underserved Asian Americans with Chronic Hepatitis B (CHB) through a Multicomponent Culturally Tailored Intervention: A Randomized Controlled Trial. Healthcare (Basel) 2022;10:1944. [PMID: 36292391 DOI: 10.3390/healthcare10101944] [Reference Citation Analysis]
5 Wong RJ, Kaufman HW, Niles JK, Kapoor H, Gish RG. Simplifying Treatment Criteria in Chronic Hepatitis B: Reducing Barriers to Elimination. Clin Infect Dis 2022:ciac385. [PMID: 35594550 DOI: 10.1093/cid/ciac385] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Scarponi CFO, Pedrosa MAF, Mol MPG, Hardman MJM, Greco DB. Low eligibility for hepatitis B treatment in the Brazilian public health system. Rev Soc Bras Med Trop 2022;55:e02972021. [PMID: 35416869 DOI: 10.1590/0037-8682-0297-2021] [Reference Citation Analysis]
7 Ma GX, Zhu L, Lu W, Tan Y, Truehart J, Johnson C, Handorf E, Nguyen MT, Yeh MC, Wang MQ. Examining the Influencing Factors of Chronic Hepatitis B Monitoring Behaviors among Asian Americans: Application of the Information-Motivation-Behavioral Model. Int J Environ Res Public Health 2022;19:4642. [PMID: 35457509 DOI: 10.3390/ijerph19084642] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Shim JJ, Kim GA, Oh CH, Kim JW, Myung J, Kim BH, Oh IH. Reduced liver cancer mortality with regular clinic follow-up among patients with chronic hepatitis B: A nationwide cohort study. Cancer Med 2020;9:7781-91. [PMID: 32857923 DOI: 10.1002/cam4.3421] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
9 Ispas S, So S, Toy M. Barriers to Disease Monitoring and Liver Cancer Surveillance Among Patients with Chronic Hepatitis B in the United States. J Community Health 2019;44:610-25. [PMID: 30539329 DOI: 10.1007/s10900-018-00604-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
10 Sbarigia U, Kariburyo F, Sah J, Colasurdo J, Xie L, Katz EG, Sylvester S. Evaluating the Effect of Standard of Care Treatment on Burden of Chronic Hepatitis B: A Retrospective Analysis of the United States Veterans Population. Adv Ther 2020;37:1156-72. [PMID: 32009232 DOI: 10.1007/s12325-020-01240-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
11 Hyun CS, Ko O, Lee S, McMenamin J. Long term outcome of a community-based hepatitis B awareness campaign: eight-year follow-up on linkage to care (LTC) in HBV infected individuals. BMC Infect Dis 2019;19:638. [PMID: 31319805 DOI: 10.1186/s12879-019-4283-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
12 Hafeez QU, Butt AS, Ahmed F. Management of Chronic Hepatitis B: Knowledge and Practices of Physicians in Pakistan. J Clin Exp Hepatol 2018;8:342-51. [PMID: 30563995 DOI: 10.1016/j.jceh.2017.12.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
13 Gao Y, Zheng J, Liang P, Tong M, Wang J, Wu C, He X, Liu C, Zhang S, Huang L, Jiang T, Cheng C, Meng F, Mu X, Lu Y, Li Y, Ai H, Qiao X, Xie XY, Wang W, Yin LP, Wu YY, Zheng R. Liver Fibrosis with Two-dimensional US Shear-Wave Elastography in Participants with Chronic Hepatitis B: A Prospective Multicenter Study. Radiology 2018;289:407-15. [PMID: 30040048 DOI: 10.1148/radiol.2018172479] [Cited by in Crossref: 47] [Cited by in F6Publishing: 49] [Article Influence: 11.8] [Reference Citation Analysis]
14 Liou IW, Nguyen MH. The Cascade of Care in Chronic Hepatitis B. Curr Hepatology Rep 2016;15:209-19. [DOI: 10.1007/s11901-016-0316-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
15 Spradling PR, Xing J, Rupp LB, Moorman AC, Gordon SC, Teshale ET, Lu M, Boscarino JA, Trinacty CM, Schmidt MA, Holmberg SD; Chronic Hepatitis Cohort Study (CHeCS) Investigators. Infrequent Clinical Assessment of Chronic Hepatitis B Patients in United States General Healthcare Settings. Clin Infect Dis 2016;63:1205-8. [PMID: 27486115 DOI: 10.1093/cid/ciw516] [Cited by in Crossref: 4] [Cited by in F6Publishing: 13] [Article Influence: 0.7] [Reference Citation Analysis]
16 Serper M, Choi G, Forde KA, Kaplan DE. Care delivery and outcomes among US veterans with hepatitis B: A national cohort study. Hepatology 2016;63:1774-82. [PMID: 26561023 DOI: 10.1002/hep.28340] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 4.2] [Reference Citation Analysis]
17 Mellinger J, Fontana RJ. Quality of care metrics in chronic hepatitis B. Hepatology 2016;63:1755-8. [PMID: 26890464 DOI: 10.1002/hep.28500] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
18 Vu VD, Do A, Nguyen NH, Kim LH, Trinh HN, Nguyen HA, Nguyen KK, Nguyen M, Huynh A, Nguyen MH. Long-term follow-up and suboptimal treatment rates of treatment-eligible chronic hepatitis B patients in diverse practice settings: a gap in linkage to care. BMJ Open Gastroenterol 2015;2:e000060. [PMID: 26543565 DOI: 10.1136/bmjgast-2015-000060] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
19 Hauser RG, Jackson BR, Shirts BH. A bayesian approach to laboratory utilization management. J Pathol Inform 2015;6:10. [PMID: 25774321 DOI: 10.4103/2153-3539.151921] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
20 Toy M, Salomon JA, Jiang H, Gui H, Wang H, Wang J, Richardus JH, Xie Q. Population health impact and cost-effectiveness of monitoring inactive chronic hepatitis B and treating eligible patients in Shanghai, China. Hepatology 2014;60:46-55. [PMID: 24990105 DOI: 10.1002/hep.26934] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 3.3] [Reference Citation Analysis]